{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T02:21:56Z","timestamp":1788142916054,"version":"build-2803163510"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,7]]},"abstract":"<jats:p>Thiopurine-methyltransferase (TPMT) and nudix-hydrolase-15 (NUDT15) are enzymes relevant to the metabolism of thiopurine medications, used to treat immunologic disorders and malignancies. Standard dosing administered in the setting of TPMT\/NUDT15 dysfunction can cause excessive cytotoxic metabolites and life-threatening complications. We describe an adolescent with high-risk B-cell acute lymphoblastic leukemia (ALL) whose TPMT\/NUDT15 status was unknown due to lack of insurance approval for genetic testing. He subsequently developed myelosuppression and severe veno-occlusive disease (VOD) after receiving 6-mercaptopurine (6-MP). Our patient provides an example of a very rare 6-MP-related toxicity and the potential benefit of TPMT\/NUDT15 screening before initiating thiopurine therapy.<\/jats:p>","DOI":"10.1097\/mph.0000000000002883","type":"journal-article","created":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T09:03:20Z","timestamp":1716368600000},"page":"e317-e321","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["6-Mercaptopurine-associated Sinusoidal Obstructive Syndrome During Interim Maintenance I: A Case Report"],"prefix":"10.1097","volume":"46","author":[{"given":"Katie","family":"Voelz","sequence":"first","affiliation":[{"name":"Department of Pediatrics"},{"name":"Division of Pediatric Hematology, Oncology and Bone Marrow Transplant"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwendolyn","family":"Miller","sequence":"additional","affiliation":[{"name":"University of Wisconsin School of Medicine & Public Health, Madison, WI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathy","family":"Lee-Miller","sequence":"additional","affiliation":[{"name":"Department of Pediatrics"},{"name":"Division of Pediatric Hematology, Oncology and Bone Marrow Transplant"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,5,23]]},"reference":[{"key":"R1-20250804","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.clpt.2006.07.002","article-title":"The thiopurine methyltransferase genetic polymorphism is associated with thioguanine-related veno-occlusive disease of the liver in children with acute lymphoblastic leukemia","volume":"80","author":"Lennard","year":"2006","journal-title":"Clin Pharmacol Ther"},{"key":"R2-20250804","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/clpt.2010.320","article-title":"Clinical Pharmacogenetics Implementation Consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing","volume":"89","author":"Relling","year":"2011","journal-title":"Clin Pharmacol Ther"},{"key":"R3-20250804","doi-asserted-by":"crossref","first-page":"1399-1408","DOI":"10.3390\/jpm12091399","article-title":"Thiopurine S-methyltransferase polymorphisms predict hepatotoxicity in azathioprine-treated patients with autoimmune diseases","volume":"12","author":"Sheu","year":"2022","journal-title":"J Pers Med"},{"key":"R4-20250804","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.1365-2125.2005.02474.x","article-title":"Two cases of thiopurine methyltransferase (TPMT) deficiency\u2014a lucky save and a near miss with azathioprine","volume":"62","author":"Gardiner","year":"2006","journal-title":"Br J Clin Pharmacol"},{"key":"R5-20250804","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2217\/pgs-2017-0147","article-title":"Predictive role of NUDT15 variants on thiopurine-induced myelotoxicity in Asian inflammatory bowel disease patients","volume":"19","author":"Sutiman","year":"2018","journal-title":"Pharmacogenomics"},{"key":"R6-20250804","doi-asserted-by":"crossref","first-page":"341","DOI":"10.2147\/TACG.S318912","article-title":"ITPA:c.94C>A and NUDT15:c.415C>T polymorphisms and their relation to mercaptopurine-related myelotoxicity in childhood leukemia in Thailand","volume":"14","author":"Boonyawat","year":"2021","journal-title":"Appl Clin Genet"},{"key":"R7-20250804","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1080\/08880018.2022.2035027","article-title":"The effects of NUDT15 and TPMT variants on mercaptopurine treatment in Vietnamese pediatric acute lymphoblastic leukemia patients","volume":"39","author":"Nghia","year":"2022","journal-title":"Pediatr Hematol Oncol"},{"key":"R8-20250804","doi-asserted-by":"crossref","first-page":"13575","DOI":"10.18632\/oncotarget.14594","article-title":"Impact of NUDT15 polymorphisms on thiopurines-induced myelotoxicity and thiopurines tolerance dose","volume":"8","author":"Yin","year":"2017","journal-title":"Oncotarget"},{"key":"R9-20250804","doi-asserted-by":"crossref","first-page":"e572","DOI":"10.1097\/MPH.0000000000002172","article-title":"Two cases of veno-occlusive disease\/sinusoidal obstruction syndrome after thioguanine treatment for acute lymphoblastic leukemia","volume":"44","author":"Gruhn","year":"2022","journal-title":"J Pediatr Hematol Oncol"},{"key":"R10-20250804","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1038\/s41375-021-01203-7","article-title":"Hepatic sinusoidal obstruction syndrome and short-term application of 6-thioguanine in pediatric acute lymphoblastic leukemia","volume":"35","author":"Stanulla","year":"2021","journal-title":"Leukemia"},{"key":"R11-20250804","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1007\/s00280-017-3453-z","article-title":"Treatment-related sinusoidal obstruction syndrome in children with de novo acute lymphoblastic leukemia during intensification","volume":"80","author":"McAtee","year":"2017","journal-title":"Cancer Chemother Pharmacol"},{"key":"R12-20250804","doi-asserted-by":"crossref","first-page":"e121","DOI":"10.1097\/MPH.0000000000002536","article-title":"Sinusoidal obstruction syndrome of the liver associated with 6-mercaptopurine during maintenance in a child with t-cell acute lymphoblastic leukemia","volume":"45","author":"Prudowsky","year":"2023","journal-title":"J Pediatr Hematol Oncol"},{"key":"R13-20250804","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2165\/00003088-200746030-00001","article-title":"Thiopurine treatment in inflammatory bowel disease: clinical pharmacology and implication of pharmacogenetically guided dosing","volume":"46","author":"Teml","year":"2007","journal-title":"Clin Pharmacokinet"},{"key":"R15-20250804","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1023\/A:1024755521423","article-title":"Veno-occlusive disease (VOD) in Crohn\u2019s disease (CD) treated with azathioprine","volume":"48","author":"Holtmann","year":"2003","journal-title":"Dig Dis Sci"},{"key":"R16-20250804","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1046\/j.1365-2141.2003.04578.x","article-title":"Veno-occlusive disease in patients receiving thiopurines during maintenance therapy for childhood acute lymphoblastic leukaemia","volume":"123","author":"Stoneham","year":"2003","journal-title":"Br J Haematol"},{"key":"R17-20250804","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1136\/pgmj.71.840.639","article-title":"Fatal hepatotoxicity associated with 6-mercaptopurine therapy","volume":"71","author":"Laidlaw","year":"1995","journal-title":"Postgrad Med J"},{"key":"R18-20250804","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1136\/bmj.1.5170.393","article-title":"Toxic complications of treatment with 6-mercaptopurine; two cases with hepatic necrosis and intestinal ulceration","volume":"1","author":"Clark","year":"1960","journal-title":"Br Med J"},{"key":"R19-20250804","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1080\/08880010050034391","article-title":"Veno-occlusive disease of the liver associated with thiopurines in a child with acute lymphoblastic leukemia","volume":"17","author":"Merino","year":"2000","journal-title":"Pediatr Hematol Oncol"},{"key":"R20-20250804","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.26519","article-title":"Hepatic sinusoidal obstruction syndrome during maintenance therapy of childhood acute lymphoblastic leukemia is associated with continuous asparaginase therapy and mercaptopurine metabolites","volume":"64","author":"Toksvang","year":"2017","journal-title":"Pediatr Blood Cancer"},{"key":"R21-20250804","doi-asserted-by":"crossref","first-page":"e454","DOI":"10.1097\/MPH.0000000000000776","article-title":"Sinusoidal obstruction syndrome during maintenance therapy for acute lymphoblastic leukemia with 6-mercaptopurine and methotrexate: a pediatric case report","volume":"39","author":"McNerney","year":"2017","journal-title":"J Pediatr Hematol Oncol"},{"key":"R22-20250804","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/S0140-6736(06)69558-5","article-title":"Toxicity and efficacy of 6-thioguanine versus 6-mercaptopurine in childhood lymphoblastic leukaemia: a randomised trial","volume":"368","author":"Vora","year":"2006","journal-title":"Lancet"},{"key":"R23-20250804","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.4254\/wjh.v9.i26.1092","article-title":"Risk of liver disease in methotrexate treated patients","volume":"9","author":"Conway","year":"2017","journal-title":"World J Hepatol"},{"key":"R24-20250804","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1111\/bcp.12226","article-title":"Implementation of TPMT testing","volume":"77","author":"Lennard","year":"2014","journal-title":"Br J Clin Pharmacol"},{"key":"R25-20250804","first-page":"2507","article-title":"Practical pharmacogenetics: the cost effectiveness of screening for thiopurine S-methyltransferase polymorphisms in patients with rheumatological conditions treated with azathioprine","volume":"29","author":"Marra","year":"2002","journal-title":"J Rheumatol"},{"key":"R26-20250804","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jval.2013.10.007","article-title":"The cost-effectiveness of a pharmacogenetic test: a trial-based evaluation of TPMT genotyping for azathioprine","volume":"17","author":"Thompson","year":"2014","journal-title":"Value Health"},{"key":"R27-20250804","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/j.1365-2036.2004.02124.x","article-title":"Cost-effectiveness of thiopurine methyltransferase genotype screening in patients about to commence azathioprine therapy for treatment of inflammatory bowel disease","volume":"20","author":"Winter","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"R28-20250804","doi-asserted-by":"crossref","first-page":"783","DOI":"10.2217\/14622416.7.5.783","article-title":"Cost-effectiveness of pharmacogenomics in clinical practice: a case study of thiopurine methyltransferase genotyping in acute lymphoblastic leukemia in Europe","volume":"7","author":"van den Akker-van Marle","year":"2006","journal-title":"Pharmacogenomics"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000002883","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T20:06:42Z","timestamp":1754338002000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000002883"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,23]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000002883","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5,23]]},"assertion":[{"value":"2023-10-02","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-04-16","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}